AlphaRx Inc. Enters Into Joint Venture Agreement With Leading Chinese Marketing Company To Distribute Its Proprietary Pharmaceutical And Consumer Product Lines Throughout Asia

AlphaRx Inc. (OTC BB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, announced today that its wholly owned subsidiary, AlphaRx International Holdings Limited (“AIH”), has entered into a Joint Venture Agreement, (“JV”) with a leading Chinese marketing company (the “China Party”), to establish a Joint Venture Company (“JV Company”) in China, for the purpose of manufacturing, marketing and distributing AIH’s proprietary line of pharmaceutical and consumer health (over-the-counter) products in Asia.